Dina H. Dawood

Dokki, GZ 12622, Egypt

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Recent advances in thiazole-based derivatives targeting diverse anti-inflammatory pathways.

Recent advances in thiazole-based derivatives targeting diverse anti-inflammatory pathways.

Journal: RSC advances

Published: March 29, 2026

Insight into the Anticancer Potential of Imidazole-Based Derivatives Targeting Receptor Tyrosine Kinases.

Insight into the Anticancer Potential of Imidazole-Based Derivatives Targeting Receptor Tyrosine Kinases.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: November 05, 2025

Recent Advances in the Therapeutic Prospective of Heterocyclic Derivatives as COX-2 Inhibitors (2019-Present).

Recent Advances in the Therapeutic Prospective of Heterocyclic Derivatives as COX-2 Inhibitors (2019-Present).

Journal: Mini reviews in medicinal chemistry

Published: February 12, 2025

Recent advances in the therapeutic insights of thiazole scaffolds as acetylcholinesterase inhibitors.

Recent advances in the therapeutic insights of thiazole scaffolds as acetylcholinesterase inhibitors.

Journal: European journal of medicinal chemistry

Published: December 21, 2024

Hydrazone-sulfonate hybrids as potential cholinesterase inhibitors: design, synthesis and molecular modeling simulation.

Hydrazone-sulfonate hybrids as potential cholinesterase inhibitors: design, synthesis and molecular modeling simulation.

Journal: Future medicinal chemistry

Published: November 23, 2023

Synthesis and molecular docking simulation of new benzimidazole-thiazole hybrids as cholinesterase inhibitors.

Synthesis and molecular docking simulation of new benzimidazole-thiazole hybrids as cholinesterase inhibitors.

Journal: Archiv der Pharmazie

Published: April 07, 2023

Design, synthesis, anti-inflammatory evaluation and molecular docking of novel thiophen-2-ylmethylene-based derivatives as potential TNF-α production inhibitors.

Design, synthesis, anti-inflammatory evaluation and molecular docking of novel thiophen-2-ylmethylene-based derivatives as potential TNF-α production inhibitors.

Journal: Bioorganic chemistry

Published: January 24, 2022

New pyridine and chromene scaffolds as potent vasorelaxant and anticancer agents.

New pyridine and chromene scaffolds as potent vasorelaxant and anticancer agents.

Journal: RSC advances

Published: June 19, 2021

Synthesis and molecular docking study of new pyrazole derivatives as potent anti-breast cancer agents targeting VEGFR-2 kinase.

Synthesis and molecular docking study of new pyrazole derivatives as potent anti-breast cancer agents targeting VEGFR-2 kinase.

Journal: Bioorganic chemistry

Published: December 25, 2019

Synthesis and 2D-QSAR study of dispiropyrrolodinyl-oxindole based alkaloids as cholinesterase inhibitors.

Synthesis and 2D-QSAR study of dispiropyrrolodinyl-oxindole based alkaloids as cholinesterase inhibitors.

Journal: Bioorganic chemistry

Published: July 19, 2018

ZnO Nanoparticles Catalyst in the Synthesis of Bioactive Fused Pyrimidines as Anti-breast Cancer Agents Targeting VEGFR-2.

ZnO Nanoparticles Catalyst in the Synthesis of Bioactive Fused Pyrimidines as Anti-breast Cancer Agents Targeting VEGFR-2.

Journal: Medicinal chemistry (Shariqah (United Arab Emirates))

Published: February 09, 2018

Coumarinyl pyranopyrimidines as new neuropeptide S receptor antagonists; design, synthesis, homology and molecular docking.

Coumarinyl pyranopyrimidines as new neuropeptide S receptor antagonists; design, synthesis, homology and molecular docking.

Journal: Bioorganic chemistry

Published: August 09, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026